Jiangyin Beresen Pharmaceutical

Jiangyin Beresen Pharmaceutical is a biotechnology company focused on the research, development, and production of marine-derived bioactive materials for clinical applications. The company is built upon its proprietary Signal Protein (SP) technology platform, which utilizes specific proteins to modulate cellular behavior for tissue regeneration and anti-inflammatory effects. Their primary commercial products include anti-adhesion gels used in surgery and advanced dressings for chronic wound management, such as diabetic foot ulcers. Beresen maintains a strong presence in the Chinese market with integrated manufacturing capabilities that adhere to GMP standards. The company continues to expand its pipeline into dermatology and gynecological health, leveraging its expertise in protein engineering and marine biology.